Inventor returns to Frutarom as global CSO

Frutarom Switzerland Ltd. Health Business Unit has named Matthias H. Kreuter, Ph.D. as Global Chief Scientific Officer (CSO) of Frutarom BU Health, beginning January 1, 2015.

Dr Kreuter is known as the inventor of the Hyperpure Technology, a cross-flow membrane microfiltration process that eliminates lipophilic compounds from botanicals, without using solvents. He also developed the EFLA® Topline extracts. These were achieved during his time as head of the Pharmaceutical Business Division of Frutarom between 1990 and 2003. Moreover, he has 18 patents to his name.

Dr Kreuter has also written books and articles in scientific journals, Drug Research, Cell, Int. Journal of Oncology, European Journal of Clinical Nutrition. He has a PhD in physiological chemistry and cancer pharmacology from the Faculty of Medicine at Johannes Gutenberg University, Mainz, Germany, and a degree in pharmacy, from the Faculty of Pharmacy.

As the CSO, his responsibilities lie in developing the company’s phytopharmaceutical business. He reports to Holger Riemensperger, general manager of the Global Business Unit, Health, for Frutarom.

“I’m excited to welcome Dr Kreuter to our team,” Mr Riemensperger said. “D. Kreuter’s skill set, bolstered by his many years of experience, will help us lead Frutarom to the next level via high-impact growth—not only in the dietary supplements industry, but also in the food, beverage and pharmaceuticals industries.”

“It is with great pleasure I rejoin Frutarom Health team and take on the challenge of contributing my knowledge and experience toward developing a winning botanical extracts line for this dynamic marketplace,” says Dr Kreuter. “I’m proud that Frutarom’s healthy ingredients are backed up by extensive scientific research, and will do my part to help Frutarom continue to set new trends and offer innovative natural ingredients to the marketplace.”